BEARINGPOINT
Management and technology consultancy BearingPoint announced today that full-year 2019 revenues hit a record €780 million, a 6% increase from the previous year, due in particular to new revenue streams and innovative business services. The firm delivered projects for clients in over 70 countries. Bookings for 2019 came in at €949 million, which was up 15% compared to the prior year. The substantial growth in bookings points to a strong 2020. BearingPoint said its Strategy 2025, launched last year, has created a solid foundation for sustainable growth. To support growth, BearingPoint hired 1,400 people last year.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200303005041/en/
“In 2019, we laid the foundation for the future of our firm by developing our Strategy 2025. Three major ambitions drive this strategy. One, we put people in the center. Two, we’re going to outperform the market every year. Three, we’re going to be within the top three players in selected areas we decide to play,” said Managing Partner Kiumars Hamidian. “Despite difficult market conditions in certain segments and market geographies, our firm proved to be resilient and able to grow. 2020 is all about the execution of our strategy. Our backlog is strong, the market conditions in most of our countries are promising, and team spirit is extremely high.”
Strategic growth and innovation
BearingPoint established Business Services as a separate unit at the beginning of 2019. Business Services provides IP-driven digital assets and managed services beyond SaaS. The firm also accelerated the growth of its software business by further verticalizing its two product lines: BearingPoint Beyond and BearingPoint RegTech. BearingPoint Beyond is a digital platform solution provider that helps organizations reinvent their business model and grow revenue by utilizing digital platforms and partner ecosystems. BearingPoint RegTech is a leading provider of innovative regulatory and risk technology solutions and launched an international “regulatory reporting factory” last year.
To support its overall growth objectives, BearingPoint also made a strategic move by acquiring Prederi, a leading consultancy focused on public services in the UK. With the acquisition, BearingPoint continued its growth strategy in selected markets with consultancies that are highly focused and strongly differentiated.
Once again, there was a strong focus on creating innovation. More than 130 ideas, startups, and initiatives were submitted to the firm’s “Hub of Innovation,” and over 20 minimum viable products (MVPs) were developed. Market observers again singled out BearingPoint in 2019 for its innovation and strengths, with 90 analyst recognitions and various awards.
Putting people in the center
As part of putting people at the center, one of the three core ambitions of its Strategy 2025, BearingPoint established a long-term incentive plan that rewards employee loyalty. The firm also established LGBTQ+ and All Inclusive communities and expanded its (Y)Our Ways program. BearingPoint’s (Y)Our Ways is about redesigning the way people work to achieve tangible business outcomes. It leverages IP, talent, and expertise. People-centric by design, (Y)Our Ways is transforming the way BearingPoint makes a difference for its people, clients, and ecosystems.
10 years of BearingPoint – 10 years of success
In 2019, BearingPoint celebrated 10 years of success as an independent, Partner-led management and technology consultancy by giving back to people, planet, and society in the biggest CSR campaign in the firm’s history. The #10DaysOfCaring campaign saw BearingPoint’s people across its offices worldwide participate in more than 150 different activities ranging from planting trees and cycling to work to donating blood and volunteering for local nonprofits. BearingPoint said that #10DaysOfCaring underlined the firm’s culture of teamwork, creativity, and a can-do attitude.
BearingPoint used the momentum from the campaign to start new initiatives, like launching new affinity networks. The firm also signed the UN Global Compact in 2019 and committed itself to the 10 underlying principles that include environmental and climate protection. One way BearingPoint showed its commitment was by making its business travel activities climate-neutral for all its business units globally.
About BearingPoint
BearingPoint is an independent management and technology consultancy with European roots and a global reach. The company operates in three business units: The first unit covers the advisory business with a clear focus on five key areas to drive growth across all regions. The second unit provides IP-driven managed services beyond SaaS and offers business critical services to its clients supporting their business success. The third unit provides the software for successful digital transformation and regulatory requirements. It is also designed to explore innovative business models with clients and partners by driving the financing and development of start-ups and leveraging ecosystems.
BearingPoint’s clients include many of the world’s leading companies and organizations. The firm has a global consulting network with more than 10,000 people and supports clients in over 70 countries, engaging with them to achieve measurable and sustainable success.
For more information, please visit:
Homepage: www.bearingpoint.com
LinkedIn: www.linkedin.com/company/bearingpoint
Twitter: @BearingPoint
View source version on businesswire.com: https://www.businesswire.com/news/home/20200303005041/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67th American Society of Hematology (ASH) Annual Meeting6.12.2025 15:30:00 CET | Press release
Results from Phase 2a IMPRSSION study demonstrate sapablursen significantly reduced phlebotomy rate, controlled hematocrit and increased serum hepcidin Sapablursen was generally safe and well tolerated Results support further development of sapablursen in a Phase 3 study Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the oral presentation of positive results from the Phase 2a IMPRSSION study of sapablursen in patients with polycythemia vera (PV) at the 67th American Society of Hematology (ASH) Annual Meeting, taking place December 6-9, 2025, in Orlando, FL. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251206361611/en/ The results were presented by Ionis Pharmaceuticals, who discovered and developed sapablursen and conducted the IMPRSSION study. In March 2025, Ionis and Ono entered into a license agreement in which On
Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera6.12.2025 15:30:00 CET | Press release
52-Week Results from the Phase 3 VERIFY Study of Rusfertide Demonstrated Sustained Hematocrit Control and Response, Defined by Absence of Phlebotomy Eligibility, with No New Safety SignalsThese Data Build on Positive 32-Week Primary Analysis from VERIFY, Which Met its Primary Efficacy Endpoint and All Four Key Secondary EndpointsPatients Crossing Over from Placebo to Rusfertide at 32 Weeks Achieved a Similar Response Rate to Those Initially Randomized to Rusfertide, with 77.9% Achieving Absence of Phlebotomy Eligibility Between Weeks 40-52Four-Year Results from the Combined REVIVE and Long-Term Extension THRIVE Study Demonstrated a 13-Fold Reduction in Annual Rate of Phlebotomies from Baseline Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX) and Takeda (TSE:4502/NYSE:TAK) announce that new 52-week results from the pivotal Phase 3 VERIFY study evaluating rusfertide in patients with polycythemia vera (PV) will be presented in an oral presentation at the 67th American Society
Vertex Presents New Data on CASGEVY®, Including First-Ever Data in Children Ages 5-11 Years, at the American Society of Hematology Annual Meeting and Announces Plan for Global Regulatory Submissions6.12.2025 13:01:00 CET | Press release
- Data from pivotal studies of CASGEVY in children ages 5-11 years with severe sickle cell disease or transfusion-dependent beta thalassemia demonstrates the transformative potential of the therapy in younger patients -- Efficacy and safety data in children 5-11 years are consistent with the durable and positive benefit/risk profile established from clinical studies in patients 12 years of age and older -- Vertex expects to initiate global regulatory submissions for CASGEVY in children 5-11 years in 1H 2026 - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data from multiple studies demonstrating the clinical benefits of CASGEVY® (exagamglogene autotemcel) in people ages 5 years and older living with severe sickle cell disease (SCD) or transfusion-dependent beta thalassemia (TDT). The results, including the first presentation of clinical data from pivotal studies in children ages 5-11 years, and longer-term data from the pivotal studies of people with severe SCD and
Leading Global Scientists Gather at Tengchong Scientists Forum to Explore Innovative Pathways in Frontier Technologies6.12.2025 12:31:00 CET | Press release
The 2025 Tengchong Scientists Forum opened on Saturday in southwest China’s Yunnan Province, convening leading scientists and academic figures to examine innovation across frontier fields including artificial intelligence, biodiversity and quantum technology. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251205499197/en/ Opening ceremony of Tengchong Scientists Forum on 6th December, 2025 Notable participants include Nobel Physics laureate Konstantin Novoselov, Fields Medalist Efim Zelmanov and Turing Award winner Andrew Chi-Chih Yao, who join 127 academicians, 77 university presidents from China and abroad, over 400 scholars and more than 600 entrepreneurs and financiers. The gathering aims to deepen collaboration between cutting-edge research and industrial development. Under the theme “Science · AI changing the World,” the forum features ten sub-forums, academic sessions and thematic events supporting major cooperation p
Lattice Wins 2025 Global Semiconductor Alliance Award6.12.2025 00:49:00 CET | Press release
‒ Named Most Respected Public Semiconductor Company Achieving $100 Million to $500 Million in Annual Sales ‒ Lattice Semiconductor (NASDAQ: LSCC), the low power programmable leader, today announced that it was selected as ‘Most Respected Public Semiconductor Company’ at the 2025 Global Semiconductor Alliance (GSA) Awards. The GSA awards recognize companies that have demonstrated excellence through their success, vision, strategy, and future opportunities in the industry as determined by votes from GSA members. “We are honored to be recognized by the Global Semiconductor Alliance and our peers as one of 2025’s most respected public semiconductor companies. This recognition reflects the dedication of the Lattice team and the trust of our customers, partners, suppliers, and investors. Looking ahead, we remain laser-focused on driving innovation and strengthening our role as the trusted low power programmable leader for semiconductor and system solutions,” said Ford Tamer, Chief Executive
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom